Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
Earnings Data
Report Date
Oct 22, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.59Last Year’s EPS
0.67Same Quarter Last Year
Moderate Buy
Based on 25 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with better-than-expected sales growth and increased full-year guidance. Key product groups like TAVR and TMTT showed significant growth, and strategic approvals were secured. However, there were challenges related to manufacturing costs, foreign exchange impacts, and competitive pressures in certain markets.Company Guidance
Strong Double-Digit Sales Growth
Edwards Lifesciences reported double-digit sales growth in Q2 2025, with total sales of $1.53 billion, representing a 10.6% increase year-over-year, which was better than expected.
Increased Full Year Guidance
The company raised its full year 2025 sales growth guidance to 9% to 10% and adjusted EPS guidance to the high end of the original range of $2.40 to $2.50.
TAVR Sales Performance
TAVR global sales were $1.1 billion, a 7.8% increase over the prior year, with growth comparable in the U.S. and outside the U.S. (OUS). The competitive position and pricing remain stable.
TMTT Impressive Growth
TMTT product group sales grew 57% to $133 million, driven by the strength of the portfolio, including PASCAL and EVOQUE.
Successful Product Approvals
Recent approvals for the SAPIEN 3 platform in the U.S. and Europe enable all severe AS patients to be evaluated for treatment with TAVR.
New Leadership Transition
Dan Lippis will take over the TAVR franchise leadership globally, following Larry Wood's departure, ensuring continued growth and success.
EW Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EW Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 24, 2025 | $75.80 | $80.00 | +5.54% |
Apr 23, 2025 | $70.46 | $75.13 | +6.63% |
Feb 11, 2025 | $70.91 | $75.82 | +6.92% |
Oct 24, 2024 | $70.35 | $69.38 | -1.38% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Edwards Lifesciences (EW) report earnings?
Edwards Lifesciences (EW) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).
What is Edwards Lifesciences (EW) earnings time?
Edwards Lifesciences (EW) earnings time is at Oct 22, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EW EPS forecast?
EW EPS forecast for the fiscal quarter 2025 (Q3) is 0.59.